The 3 analysts offering 12-month price forecasts for MiMedx Group Inc have a median target of 10.00, with a high estimate of 23.00 and a low estimate of 8.50. The median estimate represents a +46.84% increase from the last price of 6.81.
The current consensus among 2 polled investment analysts is to Buy stock in MiMedx Group Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.07
Reporting Date Feb 23
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.